Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer [Phase 1]
This Phase 1 trial update reports termination of the INBRX-105 in combination with pembrolizumab across multiple solid tumors, including hea…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
A completed clinical trial evaluating disease burden and tumor biology in metastatic renal cell carcinoma using tumor cell free DNA.
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated Fatigue [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the safety and preliminary efficacy of meldonium in patients with metastatic renal cell carcinoma and…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Renal Cell Carcinoma Microenvironment Discovery Project
This update indicates the Renal Cell Carcinoma Microenvironment Discovery Project has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS) [Phase 4]
Phase 4 clinical trial evaluating whether contrast-enhanced ultrasound findings correlate with pathologic grade in renal masses; the study w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC
A completed clinical trial evaluating whether inflammatory markers ICC and MCVL can predict response to nivolumab in metastatic renal cell c…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.
Pfizer-sponsored study in the Hospital District of Southwest Finland has completed and describes the kidney cancer patient population, treat…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Pfizer completed a post-marketing drug-use investigation for temsirolimus in renal cell carcinoma. The trial results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]
Pfizer-sponsored STAR-TOR registry study update reports completion and posted results for a three-drug regimen of temsirolimus, sunitinib, a…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Neoadjuvant Therapy of Pembrolizumab Plus Lenvatinib in Advanced RCC [Phase 2]
Phase 2 neoadjuvant trial of pembrolizumab plus lenvatinib in advanced renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients [Phase 1]
Phase 1 trial of the personalized neoantigen vaccine IVAC-RCC-001 added to standard-of-care checkpoint inhibitor therapy for advanced renal …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC
Pfizer-sponsored master protocol evaluating treatment patterns, medication adherence, and health and economic outcomes in renal cell carcino…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating entinostat in combination with nivolumab and ipilimumab in previously treated renal cell carcinoma has been termi…
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma [NA]
A clinical trial evaluating a ketogenic diet in patients receiving treatment for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
Results from a Phase 1/2 trial of X4P-001 in participants with advanced renal cell carcinoma have been posted. The study includes the clear …
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer [Phase 2]
Phase 2 neoadjuvant trial of cabozantinib for locally advanced renal cell carcinoma has posted results. The study includes patients with cle…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
A Mayo Clinic-sponsored clinical trial investigating immunophenotyping in patients with metastatic renal cell carcinoma undergoing ablative …
-
CLINICAL_TRIALS trial_result · 2024-08-05Clinical Trial Update: A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.
This clinical trial update summarizes outcomes observed in patients with metastatic renal cell carcinoma treated with sunitinib, based on re…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Multiparametric MRI for Diagnosing Small Renal Tumors [NA]
This document reports the completion of a clinical trial evaluating multiparametric MRI as a diagnostic tool for small renal tumors.
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study of PF-07209960 in advanced or metastatic solid tumors was terminated, with results posted in July 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy [Phase 2]
Phase 2 clinical trial evaluating vorolanib in combination with sintilimab for advanced renal cell carcinoma after prior immune checkpoint i…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Ultrasound Elastography Combined With Conventional Mri in Differentiating Solid Renal Parenchyma Masses
This clinical trial evaluates whether ultrasound elastography combined with conventional MRI improves differentiation of solid renal parench…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: SAbR For Oligo-Progressive Renal Cell Cancer. [Phase 2]
A Phase 2 clinical trial evaluating stereotactic ablative radiotherapy for oligoprogressive renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Study of RO7515629 in Participants With HLA-G Positive Solid Tumors [Phase 1]
This Phase 1 study of RO7515629 in participants with HLA-G positive solid tumors has been terminated. The trial enrolled patients with renal…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC) [Phase 1]
This Phase 1 trial update reports results for combining cabozantinib (Cabometyx) with avelumab in patients with metastatic renal cell carcin…